Quality & complianceOfficial

Denmark flags supply problems with Baxter's Sendoxan 50 mg cyclophosphamide tablets until early December

🇩🇰 DKMA · Wed 18 Nov 2026

The Danish Medicines Agency attributes the Sendoxan 50 mg shortage to production problems and says dispensing permits can be sought while supply remains disrupted.

The Danish Medicines Agency (DKMA) has reported current supply problems with Sendoxan 50 mg coated tablets from Baxter A/S. The notice was first published on 14 July 2026 and updated on 18 November 2026.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Official source: DKMA ↗

Article written by VigiEye from the official source (DKMA). AI-assisted; check the source before acting.